{"ticker": {"uuid": "24607ffe-2beb-4b1e-a4e7-a7ecc32abb1a", "symbol": "6660", "name": "AIM Vaccine Co., Ltd.", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "AIM's Serum-Free Iterative Rabies Vaccine Receives Acceptance for Market Registration; Institutions Predict Significant Valuation Recovery Potential for the Company", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAJBVV95cUxOYkQ1MTJYbkNBN3J2WnFvWThLT0RpcVI2MnJDSEVsQWlFRE1kMlRJRnAwTmJEUGMyMjRlSlFVT3NjWnFjeDI4X1ZocmE0d1BteFdLM09DTTVXb3E2RE10cGFWQzBmZlFPUVBiaFJMamxPLVNIbTVQak5sV0M0NW9oeEROWjVCSnV5aVlMcS1HNjQ0dXEzZVhpUlJOVUtxeUlGejlEaTNCeUNrVExBRjNidk9fQ3FZNUF4dFZZZENoOXp3dy0tOURocWdtdTh3WHBNbUMwU0tteWxHcGVHeGlocVVNRGlKNHphQVdNZnZTUTJjRVZOd1ZNQU5SYTA2WnEyUS1sQmh0X0FBZ0J0QTEtRmI5alBVOWg5?oc=5", "source_name": "Macau Business", "published_at": "2025-04-08T07:00:00+00:00", "published_display": "08 Apr 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aim seeks approval of first serum-free human rabies vaccine", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNNTZ3VGFtajd1MWhjWDRJSjJpRl9ONFFZVGJKdTVybjN5TDZCdkNueXE2cGhYcjB1RUhoQjNad0NvanlqWFdsNXpqU0ZhWWxfbmVON0ZzVUcwMGVaUkhITzBvRENidTc5Yk9wTmFBdXdoWXR4RGJmd0tEZEY5OVJQbWc2UzFIalotbVpOcnR1bmctQmxMY1NMNUI0UWxydEV5TFE?oc=5", "source_name": "BioWorld News", "published_at": "2025-03-18T07:00:00+00:00", "published_display": "18 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIM Vaccine Integrates DeepSeek: Innovative Technology and Growth Potential Support Valuation Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPUWxlamVhRFRVUTdPbGZ4cDQweDlnZmd4SThERy01M0xlLVFLeGJmRlVOTEk1aFNTM3dlNC1vaFI4NS1XUTVYSlpDWHNPVzMwNmlTOFZwVUs5YmhhUTB2WVp2VktQVGt5LUpxS0xQVkRnSm5ad1RYaS1MVFVNWGNTRDlyb3MzUGJKazI0M01FOXYzdGtlYldQY0M5aDVqMHlncTlUTUVNTUI5VFFlWDVuMVdJZDhGT2hxb3RianVWR2pzTWdR?oc=5", "source_name": "Macau Business", "published_at": "2025-02-24T08:00:00+00:00", "published_display": "24 Feb 2025 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The bull market of innovative drug technology is booming, and the leading stock AIM Vaccine has erupted upward", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQdkFjdVlndDU3aUJFQm5vSDhBRVo3RkE0SFAzaFh3SE9NcTVoV0lYZVJ4Q0lzRGJnaWZsZG9yZnBwNThYd1FrVlRpQkNCSGhISTg1bU5QN3JqQWZiQ3BZT1pNLVB5c0p2UmxHbVdMeXFoYXpMLVZaYUxfc2dkTDUxRGthUUVtWUNVVWl0WjNjWkszSnI0RHBMNHEwaDhvXzI0S3JHd29rQ0VEbTl1UGJZQU96Ny1jaElpUjZ0UENWNDdyaklvYWpsdExYNFpCRVowbEE?oc=5", "source_name": "Macau Business", "published_at": "2024-10-02T07:00:00+00:00", "published_display": "02 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIM Vaccine Announces 2023 Annual Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE11WUFZYV82XzVySHhnYXNZc0hjOFFRc3hVcHBVWlRMQzBSQzdMQ0p2VWtkSzZWbXQ5TEdVVnQtNGN6Q2pYX0NXYXJTRmJNN296NjM3SXZsSjFBZXE3MjFrejlCVUdSVW9DNkRrOVNhUDF2VDhHUkJj?oc=5", "source_name": "Macau Business", "published_at": "2024-03-28T07:00:00+00:00", "published_display": "28 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIM Vaccine Enters the Period of Explosive Growth in Major Single Products", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPdFVzT2t5OE5EVzIxd295MkwtNTdac0tiZVJRa3FlUXJCQTYxYjFKZ2VpbldNRzZqX0hYM2EteXYzcDVqNk5hUENFV0ZwRHZFTWtscG8taE9Ud3ZNd3I0dmt1ZnVRaGNFRnE1cHpwWEM0Q2ZCc09PazJSUnRKbVhYS0xHeHZrQkRtaXo2am5aMWcwSVR1QmpELVRQQ19DU19MZl9j?oc=5", "source_name": "Macau Business", "published_at": "2024-03-04T08:00:00+00:00", "published_display": "04 Mar 2024 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIM VACCINE CO., LTD. - H SHARES (6660) - stock price, quote, history", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQSU1JRWhjOGZQZGpxMnIwenhNWGxab0xUX1l2b1Nld3dDaE5mb2VQYnA3bHc0a01nNkkyblpuODEzS0RSZXVFUW9KTnV3VUQxZEhnaVlfWXJ0NTB3VFVTNUJieXNRNFB1bmhUV2NDWGs5R2lnOUsyZ2tTM2poaU1PS2xUQ1k4d1ZyRFhmYXJSUQ?oc=5", "source_name": "hkex.com.hk", "published_at": "2022-10-06T07:00:00+00:00", "published_display": "06 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "AIM's Serum-Free Iterative Rabies Vaccine Receives Acceptance for Market Registration; Institutions Predict Significant Valuation Recovery Potential for the Company", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAJBVV95cUxOYkQ1MTJYbkNBN3J2WnFvWThLT0RpcVI2MnJDSEVsQWlFRE1kMlRJRnAwTmJEUGMyMjRlSlFVT3NjWnFjeDI4X1ZocmE0d1BteFdLM09DTTVXb3E2RE10cGFWQzBmZlFPUVBiaFJMamxPLVNIbTVQak5sV0M0NW9oeEROWjVCSnV5aVlMcS1HNjQ0dXEzZVhpUlJOVUtxeUlGejlEaTNCeUNrVExBRjNidk9fQ3FZNUF4dFZZZENoOXp3dy0tOURocWdtdTh3WHBNbUMwU0tteWxHcGVHeGlocVVNRGlKNHphQVdNZnZTUTJjRVZOd1ZNQU5SYTA2WnEyUS1sQmh0X0FBZ0J0QTEtRmI5alBVOWg5?oc=5", "source_name": "Macau Business", "published_at": "2025-04-08T07:00:00+00:00", "published_display": "08 Apr 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aim seeks approval of first serum-free human rabies vaccine", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNNTZ3VGFtajd1MWhjWDRJSjJpRl9ONFFZVGJKdTVybjN5TDZCdkNueXE2cGhYcjB1RUhoQjNad0NvanlqWFdsNXpqU0ZhWWxfbmVON0ZzVUcwMGVaUkhITzBvRENidTc5Yk9wTmFBdXdoWXR4RGJmd0tEZEY5OVJQbWc2UzFIalotbVpOcnR1bmctQmxMY1NMNUI0UWxydEV5TFE?oc=5", "source_name": "BioWorld News", "published_at": "2025-03-18T07:00:00+00:00", "published_display": "18 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIM Vaccine Integrates DeepSeek: Innovative Technology and Growth Potential Support Valuation Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPUWxlamVhRFRVUTdPbGZ4cDQweDlnZmd4SThERy01M0xlLVFLeGJmRlVOTEk1aFNTM3dlNC1vaFI4NS1XUTVYSlpDWHNPVzMwNmlTOFZwVUs5YmhhUTB2WVp2VktQVGt5LUpxS0xQVkRnSm5ad1RYaS1MVFVNWGNTRDlyb3MzUGJKazI0M01FOXYzdGtlYldQY0M5aDVqMHlncTlUTUVNTUI5VFFlWDVuMVdJZDhGT2hxb3RianVWR2pzTWdR?oc=5", "source_name": "Macau Business", "published_at": "2025-02-24T08:00:00+00:00", "published_display": "24 Feb 2025 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The bull market of innovative drug technology is booming, and the leading stock AIM Vaccine has erupted upward", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQdkFjdVlndDU3aUJFQm5vSDhBRVo3RkE0SFAzaFh3SE9NcTVoV0lYZVJ4Q0lzRGJnaWZsZG9yZnBwNThYd1FrVlRpQkNCSGhISTg1bU5QN3JqQWZiQ3BZT1pNLVB5c0p2UmxHbVdMeXFoYXpMLVZaYUxfc2dkTDUxRGthUUVtWUNVVWl0WjNjWkszSnI0RHBMNHEwaDhvXzI0S3JHd29rQ0VEbTl1UGJZQU96Ny1jaElpUjZ0UENWNDdyaklvYWpsdExYNFpCRVowbEE?oc=5", "source_name": "Macau Business", "published_at": "2024-10-02T07:00:00+00:00", "published_display": "02 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIM Vaccine Announces 2023 Annual Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE11WUFZYV82XzVySHhnYXNZc0hjOFFRc3hVcHBVWlRMQzBSQzdMQ0p2VWtkSzZWbXQ5TEdVVnQtNGN6Q2pYX0NXYXJTRmJNN296NjM3SXZsSjFBZXE3MjFrejlCVUdSVW9DNkRrOVNhUDF2VDhHUkJj?oc=5", "source_name": "Macau Business", "published_at": "2024-03-28T07:00:00+00:00", "published_display": "28 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIM Vaccine Enters the Period of Explosive Growth in Major Single Products", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPdFVzT2t5OE5EVzIxd295MkwtNTdac0tiZVJRa3FlUXJCQTYxYjFKZ2VpbldNRzZqX0hYM2EteXYzcDVqNk5hUENFV0ZwRHZFTWtscG8taE9Ud3ZNd3I0dmt1ZnVRaGNFRnE1cHpwWEM0Q2ZCc09PazJSUnRKbVhYS0xHeHZrQkRtaXo2am5aMWcwSVR1QmpELVRQQ19DU19MZl9j?oc=5", "source_name": "Macau Business", "published_at": "2024-03-04T08:00:00+00:00", "published_display": "04 Mar 2024 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIM VACCINE CO., LTD. - H SHARES (6660) - stock price, quote, history", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQSU1JRWhjOGZQZGpxMnIwenhNWGxab0xUX1l2b1Nld3dDaE5mb2VQYnA3bHc0a01nNkkyblpuODEzS0RSZXVFUW9KTnV3VUQxZEhnaVlfWXJ0NTB3VFVTNUJieXNRNFB1bmhUV2NDWGs5R2lnOUsyZ2tTM2poaU1PS2xUQ1k4d1ZyRFhmYXJSUQ?oc=5", "source_name": "hkex.com.hk", "published_at": "2022-10-06T07:00:00+00:00", "published_display": "06 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 77, "total_relevant": 7, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 4, "score": 59, "total": 7, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1.5, "latest_week": "2026-07-10", "one_week_move": -10.2, "four_week_move": -23.5, "twelve_week_move": -43.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.57201, "market_dynamics_buy_signal": false, "relative_strength": -52.956028, "fair_value_gap": -81.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 40.3101, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-10.2% over one week, -23.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 68, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Macau Business", "count": 5}, {"label": "BioWorld News", "count": 1}, {"label": "hkex.com.hk", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 7}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}, {"label": "Regulatory and legal", "count": 1}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "59/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "7", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-10.2% over one week, -23.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "AIM's Serum-Free Iterative Rabies Vaccine Receives Acceptance for Market Registration; Institutions Predict Significant Valuation Recovery Potential for the Company"}], "updated_at": "2026-07-18T05:29:56.085186+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}